NCT02907814

Brief Summary

Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses infrared light to image patient's eyes. Some patients, such as those with an inflammatory disease called uveitis or those who have just undergone cataract surgery, have intraocular inflammation. This intraocular inflammation commonly manifests as cells that can be seen on routine microscopic clinical examination. However, the only currently available method to quantify this intraocular inflammation is by manually counting on the microscopic clinical examination. The investigators plan to use the OCT machine to image patient's eyes. The investigators will then use the images obtained from the OCT to objectively quantify the degree of intraocular inflammation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 20, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

May 6, 2019

Completed
Last Updated

May 6, 2019

Status Verified

May 1, 2019

Enrollment Period

1.6 years

First QC Date

September 7, 2016

Results QC Date

April 10, 2019

Last Update Submit

May 3, 2019

Conditions

Keywords

UveitisOptical Coherence Tomography

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Identified Inflammatory Cells on OCT Scan

    This measure pertains to the identification of cells in OCT scan of the participants. The inflammatory cells to be identified refer to white blood cells. The anterior segment OCT scan was used to attempt to identify these cells in the anterior chamber of the eyes of the participants.

    Through study completion, up to 1 year.

Secondary Outcomes (1)

  • Change in Cell Density Identified by OCT Scans Over Time

    Baseline and up to 8 weeks.

Study Arms (2)

Uveitis and Cataract Imaging Group

EXPERIMENTAL

Subjects will undergo up to three optical coherence tomography scans.

Device: Optical Coherence Tomography (OCT)

Control

EXPERIMENTAL

Control subjects will undergo a brief, non-contact eye exam and then undergo up to three optical coherence tomography scans.

Device: Optical Coherence Tomography (OCT)Other: Eye Exam

Interventions

The OCT scan is a brief, non-contact scan of the back of the eye using infrared light. Subjects will see a light and be asked to look forwards while the scan is completed.

ControlUveitis and Cataract Imaging Group

This is a brief, non-contact ocular exam.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years old
  • Intervention Arm:
  • Active anterior chamber inflammation in at least one eye as diagnosed by clinical exam
  • One of the following: 1) diagnosis of uveitis OR 2) undergone cataract extraction surgery within the previous 30 days
  • Control Arm:
  • No active intraocular inflammation based on clinical exam

You may not qualify if:

  • Corneal opacities in the affected eye
  • Anyone judged unable to understand or consent to study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Doctors Office Center

Newark, New Jersey, 07101, United States

Location

Related Publications (7)

  • Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol. 2008 Dec;146(6):813-8.e1. doi: 10.1016/j.ajo.2008.06.004. Epub 2008 Aug 8.

    PMID: 18687418BACKGROUND
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509-16. doi: 10.1016/j.ajo.2005.03.057.

    PMID: 16196117BACKGROUND
  • User Manual: SPECTRALIS HRA+OCT. Heidelberg Engineering GmbH;2012.

    BACKGROUND
  • Agarwal A, Ashokkumar D, Jacob S, Agarwal A, Saravanan Y. High-speed optical coherence tomography for imaging anterior chamber inflammatory reaction in uveitis: clinical correlation and grading. Am J Ophthalmol. 2009 Mar;147(3):413-416.e3. doi: 10.1016/j.ajo.2008.09.024. Epub 2008 Dec 3.

    PMID: 19054493BACKGROUND
  • Li Y, Lowder C, Zhang X, Huang D. Anterior chamber cell grading by optical coherence tomography. Invest Ophthalmol Vis Sci. 2013 Jan 9;54(1):258-65. doi: 10.1167/iovs.12-10477.

    PMID: 23249705BACKGROUND
  • Igbre AO, Rico MC, Garg SJ. High-speed optical coherence tomography as a reliable adjuvant tool to grade ocular anterior chamber inflammation. Retina. 2014 Mar;34(3):504-8. doi: 10.1097/IAE.0b013e31829f73bd.

    PMID: 23945636BACKGROUND
  • Sharma S, Lowder CY, Vasanji A, Baynes K, Kaiser PK, Srivastava SK. Automated Analysis of Anterior Chamber Inflammation by Spectral-Domain Optical Coherence Tomography. Ophthalmology. 2015 Jul;122(7):1464-70. doi: 10.1016/j.ophtha.2015.02.032. Epub 2015 Apr 4.

    PMID: 25846846BACKGROUND

MeSH Terms

Conditions

Uveitis

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Uveal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Limitations and Caveats

Insufficient enrollment and follow up leading to small numbers of subjects analyzed.

Results Point of Contact

Title
Dr. Elliot Crane
Organization
Rutgers New Jersey Medical School

Study Officials

  • David S Chu, MD

    Rutgers University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

September 7, 2016

First Posted

September 20, 2016

Study Start

September 1, 2016

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

May 6, 2019

Results First Posted

May 6, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations